ReviewERJ open research2020
Pulmonary alveolar microlithiasis: no longer in the stone age.
Review in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.
- New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review.Orphanet journal of rare diseases · 2023Pooled it
- Differences in genetic characteristics between Chinese and non-Chinese patients with pulmonary alveolar microlithiasis-case series and a systematic review.Therapeutic advances in respiratory diseasePooled it
- A compound heterozygous combination of SLC34A2 variants in pulmonary alveolar microlithiasis: A case report and literature review.The Journal of international medical research · 2026Review
- Article
- A novel homozygous frameshift mutation in exon 13 of SLC34A2 gene causing pulmonary alveolar microlithiasis: A case report.Respiratory medicine case reports · 2026Article
- Article
- Article
- Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025Review
- Successful bilateral lung transplantation in pulmonary alveolar microlithiasis: A case report and review of literature.The clinical respiratory journal · 2024Review
- Alveolar Microlithiasis with Mild Clinical Symptoms But Severe Imaging Findings: A Case Report.Clinical medicine insights. Case reports · 2024Article
- Two novel gene mutations identified in a child with pulmonary alveolar microlithiasis complicated with bronchitis obliterans: A case report and literature review.Clinical case reports · 2023Article
- Precalcific phase of pulmonary alveolar microlithiasis.BMJ case reports · 2022Article
- Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis.Human genomics · 2022Article
- Pulmonary Alveolar Microlithiasis - A Review.The Yale journal of biology and medicine · 2021Review
- Pulmonary Alveolar Microlithiasis: A Unique Case of Familial PAM Complicated by Transplant Rejection.Case reports in pathology · 2021Article
- A case report of pulmonary alveolar microlithiasis with pulmonary tuberculosis.Lung India : official organ of Indian Chest SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary alveolar microlithiasis (PAM) is a rare parenchymal lung disease caused by variants in the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.